DERMA PHARM A/S: Financial statements 2015
CVR: 89453119
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
DERMA PHARM A/S (CVR 89453119) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 33,330,278 and a net result of DKK 4,334,578 compared with DKK -4,349,813 the year before. That is an increase of 37.7% compared with the year before. Equity in the 2015 report amounted to DKK 14,631,781. The solvency ratio was 32.9%. The company had 56 employees in the financial year.
- Gross Profit
- DKK 33,330,278
- Profit/Loss
- DKK 4,334,578
- Equity
- DKK 14,631,781
- Total Assets
- DKK 44,516,162
- Employees
- 56
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 33.3 mio. | 4.3 mio. | 14.6 mio. | 56 |
| 2014 | - | 24.2 mio. | -4.3 mio. | 10.3 mio. | - |
| 2013 | - | 29.8 mio. | 1.6 mio. | 14.6 mio. | - |
| 2012 | - | 19.4 mio. | 1.1 mio. | 15.7 mio. | - |
Official annual report
How creditworthy is DERMA PHARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
DERMA PHARM A/S has published its annual report for 2014. Gross profit came to DKK 24,198,762, and the net result was DKK -4,349,813.
About DERMA PHARM A/S
DERMA PHARM A/S is a Danish company of the type Aktieselskab based in Fårup, founded in 1980. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named GENSAN DERMAPHARM A/S and GENSAN HYGIEJNE A/S. The management consists of Mikkel Egelund Jensen and Peter Bogh. The board consists of Jean-Yves Paul Etienne Desmottes (chair), Magdalena Jurkiewicz, Marie Anne Louise Bozec and Massimiliano Costantini. The company is owned by DERMAPHARM HOLDING A/S. The company has 138 employees (2026). In 2025, the company reported a gross profit of DKK 122,113,000 and a net result of DKK 28,500,000 compared with DKK 18,538,000 the year before. Equity in the 2025 report amounted to DKK 78,142,000.